Back

Science with impact: SingHealth Duke-NUS AMC faculty cited among world’s top researchers

Ten Duke-NUS clinician-scientists and researchers were named in Clarivate’s Highly Cited Researchers list for 2024, announced on 19 November. Many of them were also part of almost 100 researchers recognised in Stanford University’s World’s Top 2% Scientists 2024.

Professors Antonio Bertoletti and Jenny Low, as well as Assistant Professors Anthony Tan and Shirin Kalimuddin from the Emerging Infectious Diseases Programme, along with Professor Derek Hausenloy from the Cardiovascular and Metabolic Disorders Programme were recognised for their cross-field contributions by Clarivate in the company’s latest ranking.

Professor Wang Linfa from the Emerging Infectious Diseases Programme is another returnee to the list, earning his spot in the microbiology category. He is joined by Associate Professor Chen Jinmiao from the Centre for Computational Biology and Emerging Infectious Disseaes Programme Adjunct Senior Research Fellow Chia Wan Ni who were recognised for their contributions to the field of immunology.

In addition, Professors Carolyn Lam and Wong Tien Yin from the SingHealth Duke-NUS Academic Medical Centre (AMC) were among the clinician-scientists and researchers who made the list in the field of clinical medicine.

The Highly Cited Researchers list, curated by Clarivate identifies individuals who have demonstrated significant and broad influence in their field or fields of research. This is determined by a rigorous evaluation and selection process that draws on data from the Web of Science™, together with qualitative analysis performed by experts at the Institute for Scientific Information™ at Clarivate.

This year, a total of 6,636 individual researchers from institutions in 59 countries and regions have been named Highly Cited Researchers 2024, with Singapore securing the tenth spot in the Highly Cited Researchers 2024 list by country.

In addition to making the Clarivate ranking, 97 clinician-scientists and researchers from the School and the AMC ranked in the 2024 Stanford World’s Top 2% Scientists list published by Elsevier on 16 September 2024.

Compiled annually since 2019, Stanford’s list is based on the top 100,000 scientists by c-score (with and without self-citations) or a percentile rank of 2 per cent or above in sub-fields, which considers metrics other than a scientist’s number of publications in the calculations.

A total of 66 researchers from across the SingHealth Duke-NUS Academic Medical Centre (AMC) also featured in the career-long impact category—testament to the School’s and the AMC’s commitment to nurturing clinician-scientists across career stages.

They include Duke-NUS Dean Professor Thomas Coffman, Senior Vice-Dean for Research Professor Patrick Tan, Centre for Ageing Research & Education Executive Director Associate Professor Angelique Chan, and Health Services and System Research Programme Director Professor Marcus Ong. Among the clinician-scientists from the AMC recognised are Professors Pierce Chow, a senior clinician-scientist and mentor to many Duke-NUS students, and Tan Puay Hoon, Academic Chair of the SingHealth Duke-NUS Pathology Academic Clinical Programme.

Extending his heartiest congratulations to the researchers, Prof Tan said

“This recognition is a testament to the hard work and dedication of our colleagues, an achievement made possible by their commitment to excellence in research. What makes this year’s results particularly gratifying is growth of our impact as senior scientists are joined on these lists by the next generation. Their contributions have not only advanced our knowledge in science and medicine but have also inspired us to dream bigger in our quest to transform medicine and improve lives.”